Menu

Filtros : "The Medicines Company" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study (2020)

    Boccara, Franck; Kumar, Princy N; Caramelli, Bruno ; Calmy, Alexandra; Lopez, J. Antonio G; Bray, Sarah; Cyrille, Marcoli; Rosenson, Robert S

    Source: Journal of the american college of cardiology. Unidade: FM

    Subjects: ESTATINAS, COLESTEROL, DOENÇAS CARDIOVASCULARES, ANTICORPOS MONOCLONAIS, DISLIPIDEMIAS, HIV

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      BOCCARA, Franck et al. Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study. Journal of the american college of cardiology, v. 75, n. 20, p. 2570-2584, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2020.03.025. Acesso em: 05 maio 2026.

    • APA

      Boccara, F., Kumar, P. N., Caramelli, B., Calmy, A., Lopez, J. A. G., Bray, S., et al. (2020). Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study. Journal of the american college of cardiology, 75( 20), 2570-2584. doi:10.1016/j.jacc.2020.03.025

    • NLM

      Boccara F, Kumar PN, Caramelli B, Calmy A, Lopez JAG, Bray S, Cyrille M, Rosenson RS. Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study [Internet]. Journal of the american college of cardiology. 2020 ; 75( 20): 2570-2584.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/j.jacc.2020.03.025

    • Vancouver

      Boccara F, Kumar PN, Caramelli B, Calmy A, Lopez JAG, Bray S, Cyrille M, Rosenson RS. Evolocumab in HIV-Infected Patients With Dyslipidemia Primary Results of the Randomized, Double-Blind BEIJERINCK Study [Internet]. Journal of the american college of cardiology. 2020 ; 75( 20): 2570-2584.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/j.jacc.2020.03.025

  • Artigo de periodico

    Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial (2018)

    Corbalan, Ramon; Nicolau, Jose Carlos

    Source: Journal of the american college of cardiology. Unidade: FM

    Subjects: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 05 maio 2026.

    • APA

      Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037

    • NLM

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037

    • Vancouver

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 maio 05 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026